Riccardo Borgonovo

Dr. Riccardo Borgonovo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in NeuroSci
Verified
Journal Article
Open access
PDF file
RBRiccardo Borgonovo
Riccardo Borgonovo
LNLisa M. Nespoli
Lisa M. Nespoli
MCMartino Ceroni
Martino Ceroni
Lisa Marta ArnaudLisa Marta Arnaud
Lisa Marta Arnaud
LMLucia Morellini
Lucia Morellini
LSLeonardo Sacco
Leonardo Sacco
Background: attention-deficit/hyperactivity disorder (ADHD) and Alzheimer’s disease (AD) are distinct neurological conditions that may share genetic and molecular underpinnings. ADHD, a neurodevelopmental disorder, affects approximately 5% of children and 3% of adults globally, while AD, a neurodegenerative disorder, is the leading cause of dementia in older adults. Emerging evidence suggests potential overlapping contributors, including pathways related to synaptic plasticity, neuroinflammation, and oxidative stress. Methods: this systematic review investigated potential genetic predispositions linking Attention-Deficit/Hyperactivity Disorder (ADHD) and Alzheimer’s Disease (AD). Following PRISMA guidelines, a search was conducted in Web of Science, Embase, PsycINFO, and PubMed using keywords related to ADHD, AD, and genetic factors. Studies included were original human studies utilizing genetic analyses and ADHD polygenic risk scores (PRS), with AD confirmed using established diagnostic criteria. Exclusion criteria comprised non-original studies, animal research, and articles not addressing genetic links between ADHD and AD. Screening was conducted with Rayyan software (version 1.4.3), assessing relevance based on titles, abstracts, and full texts. Results:. The search identified 1450 records, of which 1092 were screened after duplicates were removed. Following exclusions, two studies met inclusion criteria. One study analyzed ADHD-PRS in 212 cognitively unimpaired older adults using amyloid-beta (Aβ) PET imaging and tau biomarkers. The findings revealed that ADHD-PRS was associated with progressive cognitive decline, increased tau pathology, and frontoparietal atrophy in Aβ-positive individuals, suggesting that ADHD genetic liability may exacerbate AD pathology. Another study assessed ADHD-PRS in a cohort of 10,645 Swedish twins, examining its association with 16 somatic conditions. The results showed modest risk increases for cardiometabolic, autoimmune, and neurological conditions, with mediation effects through BMI, education, tobacco use, and alcohol misuse, but no direct link between ADHD-PRS and dementia. Discussion and conclusions: this review highlights preliminary but conflicting evidence for a genetic intersection between ADHD and AD. One study suggests that ADHD genetic liability may exacerbate AD-related pathology in Aβ-positive individuals, whereas another large registry-based study finds no direct link to dementia, with associations largely mediated by lifestyle factors. The potential ADHD–AD relationship is likely complex and context-dependent, influenced by biomarker status and environmental confounders. Longitudinal studies integrating genetics, biomarkers, and detailed lifestyle data are needed to clarify this relationship.

24 December 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
RBRiccardo Borgonovo
Riccardo Borgonovo
MCMartino Ceroni
Martino Ceroni
LALisa Marta Arnaud
Lisa Marta Arnaud
LMLucia Morellini
Lucia Morellini
MLMarianna Lissi
Marianna Lissi
LSLeonardo Sacco
Leonardo Sacco
Background: Attention‐deficit/hyperactivity disorder (ADHD) and Alzheimer's disease (AD) are distinct neurological conditions with emerging evidence of shared genetic and molecular mechanisms. ADHD, affecting 5% of children and 3‐4% of adults worldwide, is characterized by inattention, hyperactivity, and impulsivity. AD, the leading cause of dementia, involves progressive neurodegeneration marked by amyloid‐beta (Aβ) plaques and tau tangles. Shared pathways, including synaptic plasticity, neuroinflammation, and oxidative stress, may link these disorders. Methods: A systematic review adhering to PRISMA guidelines was conducted to investigate potential genetic overlaps between ADHD and AD. Searches in PubMed, Embase, PsychInfo, and Web of Science identified studies using genetic analyses, particularly ADHD polygenic risk scores (PRS). Studies involving human participants with confirmed AD diagnoses were included. Screening and selection processes used Rayyan software. The review was conducted between October 2023 and December 2024. Results: Two studies met inclusion criteria. Leffa et al. (2023) found that ADHD‐PRS correlated with progressive cognitive decline, tau pathology, and frontoparietal atrophy in Aβ‐positive individuals. Garcia‐Argibay et al. (2022) associated ADHD‐PRS with increased risks for cardiometabolic and autoimmune conditions but found no direct link to dementia. Key genes implicated in both conditions include FOXP2, APOE ε4, and SNAP25, involved in synaptic plasticity and neuronal viability. Discussion: Findings suggest genetic liability for ADHD may exacerbate AD pathology, particularly in the presence of Aβ. Shared pathways like Wnt/mTOR signaling and neuroinflammation underscore potential intervention targets. However, conflicting evidence highlights the need for longitudinal studies tracking ADHD populations to clarify causal relationships. Conclusion: This review identifies genetic and molecular overlaps between ADHD and AD, emphasizing the potential for early identification of at‐risk populations through PRS. Future research should prioritize longitudinal studies and interventions targeting shared pathways to mitigate neurodevelopmental and neurodegenerative risks. Bibliography Garcia‐Argibay, M., du‐Rietz, E., Lu, Y., Martin, J., Haan, E., Lehto, K., Bergen, S.E., Lichtenstein, P., Larsson, H., & Brikell, I. (2022). The role of ADHD genetic risk in mid‐to‐late life somatic health conditions. Translational Psychiatry, 12 (1), 152. https://doi.org/10.1038/s41398‐022‐01919‐9 . Leffa, D.T., Gilsanz, A.H., Solomon, I.H., Salinas, J., Laibson, M.J., & Bandeen‐Roche, K.A. (2023). ADHD polygenic risk scores influence Alzheimer's disease pathology: A longitudinal biomarker study. Neurobiology of Aging . https://doi.org/10.1016/j.neurobiolaging.2023.03.015 .